Prostate Cell News Volume 13.21 | Jun 17 2022

    0
    15







    2022-06-17 | PCN 13.21


    Prostate Cell News by STEMCELL Technologies
    Vol. 13.21 – 17 June, 2022
    TOP STORY

    Chronologically Modified Androgen Receptor in Recurrent Castration-Resistant Prostate Cancer and Its Therapeutic Targeting

    ACK1 kinase–mediated androgen press release Y267 phosphorylation was a prerequisite for AR K609 acetylation, which spawned positive feedback loops at both the transcriptional and posttranslational level that regenerated and sustained high androgen receptor and ACK1 expression.
    [Science Translational Medicine]

    Full ArticlePress Release
    Virtual Conference Exhibition: Organoids
    PUBLICATIONSRanked by the impact factor of the journal

    A Mitochondrial Unfolded Protein Response Inhibitor Suppresses Prostate Cancer Growth in Mice via HSP60

    The authors showed that the two key components of the mitochondrial unfolded protein response, heat shock protein 60 and caseinolytic protease were required for the development of advanced prostate cancer.
    [Journal of Clinical Investigation]

    AbstractGraphical Abstract

    The Improved Killing of Both Androgen-Dependent and Independent Prostate Cancer Cells by Etoposide Loaded SPIONs Coupled with NIR Irradiation

    For the enhanced killing of PCa cells that were either androgen-dependent or not, the combination of superparamagnetic iron oxide nanoparticles based etoposide delivery and mild hyperthermia triggered by laser irradiation is proposed for the first time in the literature.
    [Biomaterials Science]

    AbstractGraphical Abstract

    Identification of Biomarkers for Immunotherapy Response in Prostate Cancer and Potential Drugs to Alleviate Immunosuppression

    Co-expression networks were constructed and survival analysis was applied to hub genes. Drug candidates to alleviate immunosuppression were filtered in prostate cancer using GSEA based on hub genes.
    [Aging]

    Full Article

    α-Terthienyl Induces Prostate Cancer Cell Death through Inhibiting Androgen Receptor Expression

    Researchers found α- terthienyl could inhibit the cell viability of four prostate cancer cell lines, especially on LNCaP and 22Rv1 cells which endogenously express androgen receptor.
    [Biomedicine & Pharmacotherapy]

    Full ArticleGraphical Abstract

    Single-Cell Transcriptional Regulation and Genetic Evolution of Neuroendocrine Prostate Cancer

    Scientists characterized ADPC and neuroendocrine prostate cancer in prostate tumors from seven patients using scRNA-seq.
    [iScience]

    AbstractFull ArticleGraphical Abstract

    Recapitulating Tumor Hypoxia in a Cleanroom-Free, Liquid-Pinning-Based Microfluidic Tumor Model

    Investigators designed a highly tunable microfluidic device that induced hypoxia through natural cell metabolism and oxygen diffusion barriers.
    [ACS Biomaterials Science & Engineering]

    AbstractGraphical Abstract

    Apigenin Impedes Cell Cycle Progression at G2 Phase in Prostate Cancer Cells

    Researchers demonstrated that apigenin arrests prostate cancer cells at G2 phase by flow cytometric analysis of prostate cancer cells co-stained for phospho-Histone H3 and DNA.
    [Discover Oncology]

    Full ArticleGraphical Abstract
    Enjoy your weekend. Your cells will too. Reduce medium acidosis with mTeSR™ Plus.
    REVIEWS

    ATP-Gated P2X7 Receptor as a Potential Target for Prostate Cancer

    Studies have shown that the P2X7 receptor is abnormally expressed in prostate cancer, and is related to the level of prostate-specific antigen, P2X7 receptor may be an early biomarker of prostate cancer.
    [Human Cell]

    Abstract
    INDUSTRY AND POLICY NEWS

    O’Neal Comprehensive Cancer Center at UAB awarded $27.5 million by National Cancer Institute

    The O’Neal Comprehensive Cancer Center at the University of Alabama at Birmingham has been awarded a five-year Cancer Center Core Support Grant of $27,477,570 from the National Cancer Institute.
    [The University of Alabama at Birmingham]

    Press Release

    FEATURED EVENT

    Immuno US

    October 3 – 4, 2022
    San Diego, California, United States

    > See All Events

    JOB OPPORTUNITIES

    Analytical Scientist – Molecular Oncology

    Institute of Cancer Research – London, England, United Kingdom

    Postdoctoral Position – Cancer Biology and Immunotherapies

    Sanford Research – Sioux Falls, South Dakota, United States

    Postdoctoral Fellow – Cancer Immunology & Genomics

    La Jolla Institute for Immunology – La Jolla, California, United States

    Postdoctoral Position – Cancer Biology and Immunotherapies

    Sanford Research – Sioux Falls, South Dakota, United States

    Postdoctoral Scientist – Translational Oncogenomics

    CRUK Manchester Institute – Manchester, United Kingdom

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Prostate Cell News Twitter